## MICHELE REDELL

| | Title| Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Pediatrics  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=O6cjwWfELcXwQpo%3d&rnd=87a36b76-91cc-46de-9b3f-3d0c4f131fe1)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=269414)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=269414&cachekey=2a76bb80-413b-47ca-8474-b694fc0a0655)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Overview  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
keywords

  * [single cell profiling](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=single cell profiling&exactphrase=false)
  * [acute myeloid leukemia](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=acute myeloid leukemia&exactphrase=false)
  * [pediatric leukemia](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=pediatric leukemia&exactphrase=false)
  * [patient derived xenograft](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=patient derived xenograft&exactphrase=false)
  * [microenvironment](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=microenvironment&exactphrase=false)
  * [cytokine](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=cytokine&exactphrase=false)
  * [growth factor](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=growth factor&exactphrase=false)
  * [targeted therapies](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=targeted therapies&exactphrase=false)
  * [chemotherapy resistance](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=chemotherapy resistance&exactphrase=false)

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Research  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
research activities and funding

R21CA234529 (REDELL, MICHELE S)Dec 1, 2019 - May 31, 2022NIH  
High-Dimensional Profiling of Physiological Signaling Responses to Identify
Relapse-Driving Cells in Acute Myeloid Leukemia  
Role: Principal Investigator  
---  
  
* * *  
  
R01CA175026 (REDELL, MICHELE S)Aug 1, 2014 - Jul 30, 2019NIH  
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML  
Role: Principal Investigator  
  
* * *  
  
K08HL085018 (REDELL, MICHELE S)Sep 10, 2008 - May 31, 2013NIH  
Stat3 Isoforms in Maturation and Survival of Normal and Malignant Myeloid
Cells  
Role: Principal Investigator  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. [Stevens AM](https://profiles.viictr.org/profile/1826717), Terrell M, Rashid R, [Fisher KE](https://profiles.viictr.org/profile/8451894), [Marcogliese AN](https://profiles.viictr.org/profile/266792), [Gaikwad A](https://profiles.viictr.org/profile/266018), Rao P, [Vrana C](https://profiles.viictr.org/profile/40909202), Krueger M, Loken M, Menssen AJ, Cook JA, Keogh N, Alozie M, Oviedo H, Gonzalez AK, Ilangovan T, Kim J, Sandhu S, **Redell MS**. Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine. Biomedicines. 2024 Feb 08; 12(2). PMID: [38397996](//www.ncbi.nlm.nih.gov/pubmed/38397996); PMCID: [PMC10886789](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10886789).

Citations:

  2. Brivio E, Pennesi E, Willemse ME, Huitema ADR, Jiang Y, van Tinteren HDR, van der Velden VHJ, Beverloo BH, den Boer ML, Rammeloo LAJ, Hudson C, Heerema N, Kowalski K, Zhao H, Kuttschreuter L, Bautista Sirvent FJ, Bukowinski A, Rizzari C, Pollard J, Murillo-Sanju?n L, Kutny M, Zarnegar-Lumley S, **Redell M** , Cooper S, Bertrand Y, Petit A, Krystal J, Metzler M, Lancaster D, Bourquin JP, Motwani J, van der Sluis IM, Locatelli F, Roth ME, Hijiya N, Zwaan CM. Bosutinib in Resistant and Intolerant Pediatric Patients With Chronic Phase Chronic Myeloid Leukemia: Results From the Phase I Part of Study ITCC054/COG AAML1921. J Clin Oncol. 2024 Mar 01; 42(7):821-831. PMID: [38033284](//www.ncbi.nlm.nih.gov/pubmed/38033284); PMCID: [PMC10906575](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10906575).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  3. Shekar M, [Llaurador Caraballo G](https://profiles.viictr.org/profile/38200597), Punia JN, [Curry CV](https://profiles.viictr.org/profile/268836), [Fisher KE](https://profiles.viictr.org/profile/8451894), **Redell MS**. ALK Fusion in an Adolescent with Acute Myeloid Leukemia: A Case Report and Review of the Literature. Biomedicines. 2023 Jun 27; 11(7). PMID: [37509482](//www.ncbi.nlm.nih.gov/pubmed/37509482); PMCID: [PMC10377196](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10377196).

Citations:

  4. Trabal A, Gibson A, He J, McCall D, Roth M, Nu?ez C, Garcia M, Buzbee M, Toepfer L, Bidikian A, [Daver N](https://profiles.viictr.org/profile/12583574), [Kadia T](https://profiles.viictr.org/profile/12583065), Short NJ, Issa GC, Ravandi F, [DiNardo CD](https://profiles.viictr.org/profile/12583624), Montalban Bravo G, Garces S, [Marcogliese A](https://profiles.viictr.org/profile/266792), [Paek H](https://profiles.viictr.org/profile/30445271), Dreyer Z, [Brackett J](https://profiles.viictr.org/profile/265632), **Redell M** , [Yi J](https://profiles.viictr.org/profile/15317815), [Garcia-Manero G](https://profiles.viictr.org/profile/12583738), [Konopleva M](https://profiles.viictr.org/profile/12583701), [Stevens A](https://profiles.viictr.org/profile/1826717), Cuglievan B. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience. Cancers (Basel). 2023 Mar 26; 15(7). PMID: [37046645](//www.ncbi.nlm.nih.gov/pubmed/37046645); PMCID: [PMC10093646](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10093646).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37046645/citedby/)

  5. [Stevens AM](https://profiles.viictr.org/profile/1826717), [Schafer ES](https://profiles.viictr.org/profile/270055), Li M, Terrell M, Rashid R, [Paek H](https://profiles.viictr.org/profile/30445271), Bernhardt MB, Weisnicht A, Smith WT, Keogh NJ, Alozie MC, Oviedo HH, Gonzalez AK, Ilangovan T, Mangubat-Medina A, Wang H, Jo E, Rabik CA, [Bocchini C](https://profiles.viictr.org/profile/267713), [Hilsenbeck S](https://profiles.viictr.org/profile/268374), Ball ZT, Cooper TM, **Redell MS**. Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated. Cancers (Basel). 2023 Feb 20; 15(4). PMID: [36831684](//www.ncbi.nlm.nih.gov/pubmed/36831684); PMCID: [PMC9954468](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9954468).

Citations:

  6. [Stevens AM](https://profiles.viictr.org/profile/1826717), [Horton TM](https://profiles.viictr.org/profile/266755), Glasser CL, Gerbing RB, Aplenc R, Alonzo TA, **Redell MS**. IL-10 and TNFa are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report. Pediatr Hematol Oncol. 2023 Mar; 40(2):147-158. PMID: [35838057](//www.ncbi.nlm.nih.gov/pubmed/35838057); PMCID: [PMC10498011](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10498011).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

  7. Youn M, Smith SM, Lee AG, Chae HD, Spiteri E, Erdmann J, Galperin I, Jones LM, Donato M, Abidi P, Bittencourt H, Lacayo N, Dahl G, Aftandilian C, Davis KL, Matthews JA, [Kornblau SM](https://profiles.viictr.org/profile/12583281), Huang M, Sumarsono N, **Redell MS** , Fu CH, Chen IM, Alonzo TA, Eklund E, Gotlib J, Khatri P, Sweet-Cordero EA, Hijiya N, Sakamoto KM. Comparison of the Transcriptomic Signatures in Pediatric and Adult CML. Cancers (Basel). 2021 Dec 14; 13(24). PMID: [34944883](//www.ncbi.nlm.nih.gov/pubmed/34944883); PMCID: [PMC8699058](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8699058).

Citations:

  8. [Stevens AM](https://profiles.viictr.org/profile/1826717), **Redell MS**. Introduction to the Special Issue on Pediatric Acute Myeloid Leukemia: Current Management and Future Directions. Children (Basel). 2021 Aug 12; 8(8). PMID: [34438589](//www.ncbi.nlm.nih.gov/pubmed/34438589); PMCID: [PMC8394900](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8394900).

Citations:

  9. Narayanan P, [Man TK](https://profiles.viictr.org/profile/266960), Gerbing RB, Ries R, [Stevens AM](https://profiles.viictr.org/profile/1826717), Wang YC, Long X, Gamis AS, Cooper T, Meshinchi S, Alonzo TA, **Redell MS**. Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia. Clin Transl Oncol. 2021 Oct; 23(10):2141-2154. PMID: [33948920](//www.ncbi.nlm.nih.gov/pubmed/33948920); PMCID: [PMC8390401](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8390401).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCells

  10. Ataca Atilla P, [McKenna MK](https://profiles.viictr.org/profile/23496083), Tashiro H, Srinivasan M, Mo F, [Watanabe N](https://profiles.viictr.org/profile/3009961), Simons BW, McLean Stevens A, **Redell MS** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Brenner MK](https://profiles.viictr.org/profile/268200), Atilla E. Modulating TNFa activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. J Immunother Cancer. 2020 09; 8(2). PMID: [32938629](//www.ncbi.nlm.nih.gov/pubmed/32938629); PMCID: [PMC7497527](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7497527).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32938629/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  11. Minus MB, Wang H, Munoz JO, Stevens AM, Mangubat-Medina AE, Krueger MJ, Liu W, [Kasembeli MM](https://profiles.viictr.org/profile/17440149), Cooper JC, Kolosov MI, [Tweardy DJ](https://profiles.viictr.org/profile/17439982), **Redell MS** , Ball ZT. Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic-inorganic inhibitors. Org Biomol Chem. 2020 05 06; 18(17):3288-3296. PMID: [32286579](//www.ncbi.nlm.nih.gov/pubmed/32286579); PMCID: [PMC7286531](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7286531).

Citations:  Fields:

Bio BiochemistryChe Chemistry

Translation:HumansAnimalsCells

  12. [Stevens AM](https://profiles.viictr.org/profile/1826717), Xiang M, Heppler LN, [Jiang K](https://profiles.viictr.org/profile/35073120), Munoz JO, [Gaikwad AS](https://profiles.viictr.org/profile/266018), [Horton TM](https://profiles.viictr.org/profile/266755), Long X, Narayanan P, Seashore EL, Terrell MC, Rashid R, Krueger MJ, Mangubat-Medina AE, Ball ZT, [Sumazin P](https://profiles.viictr.org/profile/2560346), Walker SR, Hamada Y, Oyadomari S, **Redell MS** , Frank DA, To?ic I. Atovaquone is active against AML by upregulating the integrated stress pathway and suppressing oxidative phosphorylation. Blood Adv. 2019 12 23; 3(24):4215-4227. PMID: [31856268](//www.ncbi.nlm.nih.gov/pubmed/31856268); PMCID: [PMC6929386](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6929386).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31856268/citedby/) Fields:

Hem Hematology

Translation:HumansAnimalsCells

  13. Zhou T, Bloomquist MS, Ferguson LS, Reuther J, [Marcogliese AN](https://profiles.viictr.org/profile/266792), [Elghetany MT](https://profiles.viictr.org/profile/266095), [Roy A](https://profiles.viictr.org/profile/268647), Rao PH, [Lopez-Terrada DH](https://profiles.viictr.org/profile/266283), **Redell MS** , Punia JN, [Curry CV](https://profiles.viictr.org/profile/268836), [Fisher KE](https://profiles.viictr.org/profile/8451894). Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis. Pediatr Hematol Oncol. 2020 Feb; 37(1):76-89. PMID: [31682773](//www.ncbi.nlm.nih.gov/pubmed/31682773).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31682773/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  14. Athale U, Hijiya N, Patterson BC, Bergsagel J, Andolina JR, Bittencourt H, Schultz KR, Burke MJ, **Redell MS** , Kolb EA, Johnston DL. Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group. Pediatr Blood Cancer. 2019 09; 66(9):e27827. PMID: [31330093](//www.ncbi.nlm.nih.gov/pubmed/31330093); PMCID: [PMC6944522](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6944522).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31330093/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  15. Boudreaux SP, Duren RP, Call SG, Nguyen L, Freire PR, Narayanan P, **Redell MS** , [Conneely OM](https://profiles.viictr.org/profile/267996). Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia. 2019 01; 33(1):52-63. PMID: [29884904](//www.ncbi.nlm.nih.gov/pubmed/29884904); PMCID: [PMC6286710](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6286710).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29884904/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansAnimalsCells

  16. Lu L, Wen Y, Yao Y, Chen F, Wang G, Wu F, Wu J, Narayanan P, **Redell M** , Mo Q, [Song Y](https://profiles.viictr.org/profile/266042). Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21). Theranostics. 2018; 8(8):2189-2201. PMID: [29721072](//www.ncbi.nlm.nih.gov/pubmed/29721072); PMCID: [PMC5928880](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5928880).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29721072/citedby/) Fields:

Dia Diagnostic ImagingMol Molecular BiologyNan NanotechnologyThe Therapeutics

Translation:HumansAnimalsCells

  17. Long X, Gerbing RB, Alonzo TA, **Redell MS**. Distinct signaling events promote resistance to mitoxantrone and etoposide in pediatric AML: a Children's Oncology Group report. Oncotarget. 2017 Oct 27; 8(52):90037-90049. PMID: [29163809](//www.ncbi.nlm.nih.gov/pubmed/29163809); PMCID: [PMC5685730](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5685730).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29163809/citedby/) Fields:

Neo Neoplasms

  18. Stevens AM, Miller JM, Munoz JO, [Gaikwad AS](https://profiles.viictr.org/profile/266018), **Redell MS**. Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance. Blood Adv. 2017 Aug 08; 1(18):1387-1397. PMID: [29296780](//www.ncbi.nlm.nih.gov/pubmed/29296780); PMCID: [PMC5727855](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5727855).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29296780/citedby/) Fields:

Hem Hematology

  19. [Gramatges MM](https://profiles.viictr.org/profile/266349), Deshpande A, [Lupo PJ](https://profiles.viictr.org/profile/270034), [Rau RE](https://profiles.viictr.org/profile/270060), **Redell ML** , [Horton TM](https://profiles.viictr.org/profile/266755), [Scheurer ME](https://profiles.viictr.org/profile/265805), [Rabin KR](https://profiles.viictr.org/profile/265501). Ethnic disparities relative to disease features and outcomes in children with acute myeloid leukemia. Pediatr Blood Cancer. 2017 Sep; 64(9). PMID: [28266784](//www.ncbi.nlm.nih.gov/pubmed/28266784).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28266784/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  20. Minus MB, Kang MK, Knudsen SE, Liu W, Krueger MJ, Smith ML, **Redell MS** , Ball ZT. Assessing the intracellular fate of rhodium(ii) complexes. Chem Commun (Camb). 2016 Sep 22; 52(78):11685-11688. PMID: [27709185](//www.ncbi.nlm.nih.gov/pubmed/27709185); PMCID: [PMC5076564](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5076564).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27709185/citedby/) Fields:

Che Chemistry

  21. Bonifant CL, Szoor A, Torres D, Joseph N, Velasquez MP, Iwahori K, [Gaikwad A](https://profiles.viictr.org/profile/266018), Nguyen P, Arber C, Song XT, **Redell M** , [Gottschalk S](https://profiles.viictr.org/profile/270181). CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia. Mol Ther. 2016 09 29; 24(9):1615-26. PMID: [27401038](//www.ncbi.nlm.nih.gov/pubmed/27401038); PMCID: [PMC5113097](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5113097).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27401038/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  22. Feng Z, Yao Y, Zhou C, Chen F, Wu F, Wei L, Liu W, Dong S, **Redell M** , Mo Q, [Song Y](https://profiles.viictr.org/profile/266042). Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. J Hematol Oncol. 2016 Mar 12; 9:24. PMID: [26970896](//www.ncbi.nlm.nih.gov/pubmed/26970896); PMCID: [PMC4789278](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4789278).

Citations:
[48](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26970896/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansAnimalsCells

  23. Minus MB, Liu W, Vohidov F, [Kasembeli MM](https://profiles.viictr.org/profile/17440149), Long X, Krueger MJ, [Stevens A](https://profiles.viictr.org/profile/1826717), Kolosov MI, [Tweardy DJ](https://profiles.viictr.org/profile/17439982), Sison EA, **Redell MS** , Ball ZT. Rhodium(II) Proximity-Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti-Leukemia Activity. Angew Chem Int Ed Engl. 2015 Oct 26; 54(44):13085-9. PMID: [26480340](//www.ncbi.nlm.nih.gov/pubmed/26480340); PMCID: [PMC5041597](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5041597).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26480340/citedby/) Fields:

Che Chemistry

Translation:HumansAnimalsCells

  24. Fang M, Becker PS, Linenberger M, Eaton KD, Appelbaum FR, [Dreyer Z](https://profiles.viictr.org/profile/269653), [Airewele G](https://profiles.viictr.org/profile/269786), **Redell M** , [Lopez-Terrada D](https://profiles.viictr.org/profile/266283), Patel A, [Rabin KR](https://profiles.viictr.org/profile/265501), Lu X. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients. Am J Clin Pathol. 2015 Aug; 144(2):263-70. PMID: [26185311](//www.ncbi.nlm.nih.gov/pubmed/26185311).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26185311/citedby/) Fields:

Pat Pathology

Translation:Humans

  25. Long X, Yu Y, Perlaky L, [Man TK](https://profiles.viictr.org/profile/266960), **Redell MS**. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia. Br J Haematol. 2015 Sep; 170(5):704-18. PMID: [25974135](//www.ncbi.nlm.nih.gov/pubmed/25974135); PMCID: [PMC5490799](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5490799).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25974135/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  26. Liu W, Deng L, [Song Y](https://profiles.viictr.org/profile/266042), **Redell M**. DOT1L inhibition sensitizes MLL-rearranged AML to chemotherapy. PLoS One. 2014; 9(5):e98270. PMID: [24858818](//www.ncbi.nlm.nih.gov/pubmed/24858818); PMCID: [PMC4032273](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4032273).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24858818/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:HumansCells

  27. Blanco EM, [Curry CV](https://profiles.viictr.org/profile/268836), Lu XY, Sarabia SF, **Redell MS** , [Lopez-Terrada DH](https://profiles.viictr.org/profile/266283), [Roy A](https://profiles.viictr.org/profile/268647). Cytogenetically cryptic and FISH-negative PML/RARA rearrangement in acute promyelocytic leukemia detected only by PCR: an exceedingly rare phenomenon. Cancer Genet. 2014 Jan-Feb; 207(1-2):48-9. PMID: [24561214](//www.ncbi.nlm.nih.gov/pubmed/24561214).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24561214/citedby/) Fields:

Gen GeneticsNeo Neoplasms

Translation:HumansCells

  28. Deng L, Zhang L, Yao Y, Wang C, **Redell MS** , Dong S, [Song Y](https://profiles.viictr.org/profile/266042). Synthesis, Activity and Metabolic Stability of Non-Ribose Containing Inhibitors of Histone Methyltransferase DOT1L. Medchemcomm. 2013 May 01; 4(5):822-826. PMID: [23795283](//www.ncbi.nlm.nih.gov/pubmed/23795283); PMCID: [PMC3686528](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3686528).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23795283/citedby/)

  29. Fallon SC, **Redell MS** , El-Bietar J, Lopez ME, [Vasudevan SA](https://profiles.viictr.org/profile/269879), [Brandt ML](https://profiles.viictr.org/profile/267950). Intestinal perforation after treatment of Burkitt's lymphoma: case report and review of the literature. J Pediatr Surg. 2013 Feb; 48(2):436-40. PMID: [23414881](//www.ncbi.nlm.nih.gov/pubmed/23414881).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23414881/citedby/) Fields:

Gen General SurgeryPed Pediatrics

Translation:Humans

  30. **Redell MS** , Ruiz MJ, Gerbing RB, Alonzo TA, Lange BJ, [Tweardy DJ](https://profiles.viictr.org/profile/17439982), Meshinchi S, Children's Oncology Group. FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report. Blood. 2013 Feb 14; 121(7):1083-93. PMID: [23243289](//www.ncbi.nlm.nih.gov/pubmed/23243289); PMCID: [PMC3575754](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3575754).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23243289/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  31. **Redell MS** , Ruiz MJ, Alonzo TA, Gerbing RB, [Tweardy DJ](https://profiles.viictr.org/profile/17439982). Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor. Blood. 2011 May 26; 117(21):5701-9. PMID: [21447830](//www.ncbi.nlm.nih.gov/pubmed/21447830); PMCID: [PMC3110027](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3110027).

Citations:
[103](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21447830/citedby/)
Fields:

Hem Hematology

Translation:HumansCells

  32. Huang Y, Qiu J, Dong S, **Redell MS** , Poli V, [Mancini MA](https://profiles.viictr.org/profile/268178), [Tweardy DJ](https://profiles.viictr.org/profile/17439982). Stat3 isoforms, alpha and beta, demonstrate distinct intracellular dynamics with prolonged nuclear retention of Stat3beta mapping to its unique C-terminal end. J Biol Chem. 2007 Nov 30; 282(48):34958-67. PMID: [17855361](//www.ncbi.nlm.nih.gov/pubmed/17855361).

Citations:
[30](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17855361/citedby/) Fields:

Bio Biochemistry

Translation:HumansAnimalsCells

  33. **Redell MS** , Tsimelzon A, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Tweardy DJ](https://profiles.viictr.org/profile/17439982). Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern. J Leukoc Biol. 2007 Oct; 82(4):975-85. PMID: [17634277](//www.ncbi.nlm.nih.gov/pubmed/17634277).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/17634277/citedby/) Fields:

All Allergy and Immunology

Translation:AnimalsCells

  34. **Redell MS** , [Tweardy DJ](https://profiles.viictr.org/profile/17439982). Targeting transcription factors in cancer: Challenges and evolving strategies. Drug Discov Today Technol. 2006; 3(3):261-7. PMID: [24980527](//www.ncbi.nlm.nih.gov/pubmed/24980527).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24980527/citedby/) Fields:

Dru Drug TherapyPha Pharmacology

  35. **Redell MS** , [Tweardy DJ](https://profiles.viictr.org/profile/17439982). Targeting transcription factors for cancer therapy. Curr Pharm Des. 2005; 11(22):2873-87. PMID: [16101443](//www.ncbi.nlm.nih.gov/pubmed/16101443).

Citations:
[26](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/16101443/citedby/) Fields:

Pha Pharmacology

Translation:HumansAnimals

  36. Terman GW, Drake CT, Simmons ML, Milner TA, Chavkin C. Opioid modulation of recurrent excitation in the hippocampal dentate gyrus. J Neurosci. 2000 Jun 15; 20(12):4379-88. PMID: [10844006](//www.ncbi.nlm.nih.gov/pubmed/10844006); PMCID: [PMC6772439](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6772439).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/10844006/citedby/) Fields:

Neu Neurology

Translation:AnimalsCells

  37. Simmons ML, Terman GW, Chavkin C. Spontaneous excitatory currents and kappa-opioid receptor inhibition in dentate gyrus are increased in the rat pilocarpine model of temporal lobe epilepsy. J Neurophysiol. 1997 Oct; 78(4):1860-8. PMID: [9325355](//www.ncbi.nlm.nih.gov/pubmed/9325355).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/9325355/citedby/) Fields:

Neu NeurologyPhy Physiology

Translation:AnimalsCells

  38. Drake CT, Patterson TA, Simmons ML, Chavkin C, Milner TA. Kappa opioid receptor-like immunoreactivity in guinea pig brain: ultrastructural localization in presynaptic terminals in hippocampal formation. J Comp Neurol. 1996 Jul 01; 370(3):377-95. PMID: [8799863](//www.ncbi.nlm.nih.gov/pubmed/8799863).

Citations:
[22](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8799863/citedby/) Fields:

Neu Neurology

Translation:AnimalsCells

  39. Simmons ML, Chavkin C. k-Opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. Mol Pharmacol. 1996 Jul; 50(1):80-5. PMID: [8700123](//www.ncbi.nlm.nih.gov/pubmed/8700123).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/8700123/citedby/) Fields:

Mol Molecular BiologyPha Pharmacology

Translation:AnimalsCells

  40. Simmons ML, Terman GW, Gibbs SM, Chavkin C. L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron. 1995 Jun; 14(6):1265-72. PMID: [7605635](//www.ncbi.nlm.nih.gov/pubmed/7605635).

Citations:
[37](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7605635/citedby/) Fields:

Neu Neurology

Translation:AnimalsCells

  41. Wu ZL, Thomas SA, Villacres EC, Xia Z, Simmons ML, Chavkin C, Palmiter RD, Storm DR. Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci U S A. 1995 Jan 03; 92(1):220-4. PMID: [7816821](//www.ncbi.nlm.nih.gov/pubmed/7816821); PMCID: [PMC42849](//www.ncbi.nlm.nih.gov/pmc/articles/PMC42849).

Citations:
[108](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7816821/citedby/) Fields:

Sci Science

Translation:AnimalsCells

  42. Simmons ML, Terman GW, Drake CT, Chavkin C. Inhibition of glutamate release by presynaptic kappa 1-opioid receptors in the guinea pig dentate gyrus. J Neurophysiol. 1994 Oct; 72(4):1697-705. PMID: [7823095](//www.ncbi.nlm.nih.gov/pubmed/7823095).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7823095/citedby/) Fields:

Neu NeurologyPhy Physiology

Translation:AnimalsCells

  43. Drake CT, Terman GW, Simmons ML, Milner TA, Kunkel DD, Schwartzkroin PA, Chavkin C. Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmitters. J Neurosci. 1994 Jun; 14(6):3736-50. PMID: [7911518](//www.ncbi.nlm.nih.gov/pubmed/7911518); PMCID: [PMC6576943](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6576943).

Citations:
[45](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/7911518/citedby/) Fields:

Neu Neurology

Translation:AnimalsCells

  44. Simmons ML, Wagner JJ, Caudle RM, Chavkin C. Endogenous opioid regulation of norepinephrine release in guinea pig hippocampus. Neurosci Lett. 1992 Jul 06; 141(1):84-8. PMID: [1508405](//www.ncbi.nlm.nih.gov/pubmed/1508405).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1508405/citedby/) Fields:

Neu Neurology

Translation:Animals

  45. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991; 45(1):37-45. PMID: [1754068](//www.ncbi.nlm.nih.gov/pubmed/1754068).

Citations:
[134](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1754068/citedby/) Fields:

Neu Neurology

Translation:AnimalsCells

  46. Slusher BS, Robinson MB, Tsai G, Simmons ML, Richards SS, Coyle JT. Rat brain N-acetylated alpha-linked acidic dipeptidase activity. Purification and immunologic characterization. J Biol Chem. 1990 Dec 05; 265(34):21297-301. PMID: [2250024](//www.ncbi.nlm.nih.gov/pubmed/2250024).

Citations:
[20](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/2250024/citedby/) Fields:

Bio Biochemistry

Translation:AnimalsCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 43 publications over 22 distinct years, with a maximum of
4 publications in
2023](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|4&cht=bvs&chd=t:50,50,50,25,0,0,25,0,0,0,0,25,25,50,0,0,0,25,25,50,50,75,75,75,50,75,50,75,25,100,25&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
1994| 2  
1995| 2  
1996| 2  
1997| 1  
2000| 1  
2005| 1  
2006| 1  
2007| 2  
2011| 1  
2012| 1  
2013| 2  
2014| 2  
2015| 3  
2016| 3  
2017| 3  
2018| 2  
2019| 3  
2020| 2  
2021| 3  
2022| 1  
2023| 4  
2024| 1  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

REDELL's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (284)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [STAT3 Transcription Factor](https://profiles.viictr.org/profile/253333)
  * [STAT5 Transcription Factor](https://profiles.viictr.org/profile/247009)
  * [Leukemia, Myeloid, Acute](https://profiles.viictr.org/profile/254204)
  * [Granulocyte Colony-Stimulating Factor](https://profiles.viictr.org/profile/243491)
  * [Interleukin-10](https://profiles.viictr.org/profile/243284)

[Explore](https://profiles.viictr.org/profile/269414/198)

_

Co-Authors (47)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [STEVENS, ALEXANDRA](https://profiles.viictr.org/profile/1826717)
  * [TWEARDY, DAVID](https://profiles.viictr.org/profile/17439982)
  * [FISHER, KEVIN](https://profiles.viictr.org/profile/8451894)
  * [SONG, YONGCHENG](https://profiles.viictr.org/profile/266042)
  * [GAIKWAD, AMOS](https://profiles.viictr.org/profile/266018)

[Explore](https://profiles.viictr.org/profile/269414/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [CORTES, JORGE E](https://profiles.viictr.org/profile/12582539)
  * [KONOPLEVA, MARINA](https://profiles.viictr.org/profile/12583701)
  * [ANDREEFF, MICHAEL](https://profiles.viictr.org/profile/12582880)
  * [GARCIA-MANERO, GUILLERMO](https://profiles.viictr.org/profile/12583738)

[Explore](https://profiles.viictr.org/profile/269414/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [EL-MALLAWANY, NADER](https://profiles.viictr.org/profile/267714)
  * [PARSONS, DONALD](https://profiles.viictr.org/profile/265886)
  * [PATI, DEBANANDA](https://profiles.viictr.org/profile/266988)
  * [PLON, SHARON](https://profiles.viictr.org/profile/269771)
  * [RITTER, DEBORAH](https://profiles.viictr.org/profile/3009521)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=A81BSfTwU3GNm4liSODkW6vB3EBYO6gz+a5TY1bFhuz1tc7ngL4Orww3064KoquG+9VriFtrDjogfSknlN6Jz7ictMT0qk3g10zM0TMIEPsEyvmx6bLpcnNFGJ4exv4/fFAesBf4NHrkI4nVpsBeSKg1prKuDu5Ad3xZR2IG1VXzQt2Kl5Hs5a708T2/vlG+0DSye5g9KBjG4Q1kuBhnZAsDzRQkDR38klnZT2UlnG774nyA2dru0SIu9XaJe2Vd5sGS5MfW+ZRpNT79jDpQICGGFNfg5WTlXIPkbYJjpf3YGfCjPCJ3A81UJRyGY9MF14VFc7hjK08KUw/CXldSQkQX94mkjqn1GRbJZcV6q8YMdcbUB3UeVgUHmLQA7INKLsictgHvVcL1tc7ngL4Or2BgPoCYhvcEdI9fj5a9U4/8OigV51+oglRnSu//SLHvjH1HWb7OWmYrCEOhNlmBq7Z/PsLHWsJSZIAfV8346VMVWsQSiN3oIGGN9jLXSZC010kNGYH6yvTtuL5pI2IiiZgevCUih0f3vmYbjqDWiC08TnyRrJKGE/Ija0iyg/oaKwhDoTZZgau2fz7Cx1rCUmSAH1fN+OlTFVrEEojd6CBhjfYy10mQtNdJDRmB+sr0qj61OBf+xqDD+6Clu8wvckIBgwTrFvbm7X3tdBvSWESSFAIovZGCSzP0EoNHt5PiUF26eANDXMkWXAx5IRPustF+EEOAWlaZMfmQk2RtrZ8KVVPJ9ULGiQTN/PyW6vHZjcQbuuaMR4JpF2jOOFZEaWue6vkhtoRwwfdN4TTmOan9ztqBxhOvMb+us3lPmnf2tt1S1Z0IDTE7qPP/7M2jzFN6foNWCqqLRb/LXAdoFsRpMPt345sB8SI9K3ixiSN+kccJVanciBCNm4liSODkW2tuMX0EQMJeJ1NvmZC7MMfIH0G3DzFa7Ww3kCPpSspax47lNl+obrMAl6LnDsmqO6LI4XK0QanMi19EAkvoFc7JmZNEJTRG2uqY8pTR84tJVXfmR7Dk5CJCe/cQ6H6rtg==)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [EL-MALLAWANY, NADER](https://profiles.viictr.org/profile/267714)
  * [PARSONS, DONALD](https://profiles.viictr.org/profile/265886)
  * [REDNAM, SURYA](https://profiles.viictr.org/profile/269909)
  * [SU, JACK](https://profiles.viictr.org/profile/268196)
  * [WANG, LISA](https://profiles.viictr.org/profile/267005)

_

